Abstract:Objective The purpose of this study was to investigate the clinical significance of serum vascular endothelial growth factor(S-VEGF)in patients of esophageal squamous cell carcinoma with the end-point of progress-free survival rate.Methods Sera from 89 patients with esophageal squamous carcinoma,who presented and treated with concurrent chemoradiotherapy or surgical resection in Cancer Center d Sun Yat-Sen University from December 2002 to May 2004,were sampled at the time of pre-treatment.30 cases of health individuals without any evidence of disease were selected as control group.For patients with surgical resection were performed with esophagectomy and extended lymphadenectomy.For patients with concurrent chemoradiotherapy comprised of cisplatin and 5-fluorouracil.The radiotherapy dose of 2 Gy per day was initiated on Day 1 of chemotherapy and continued daily for 5 days per week for 6 weeks,for a total close of 60 Gy.Two courses of chemotherapy were given during radiotherapy at 6-week intervals.The serum vascular endothelial growth factor(S- VEGF)levels were measured with a solid phase enzyme Human VEGF Immunoassay ELISA kit.The end point of this study was progress-free survival,and time was calculated from the date of diagnosis to date of relapse or last follow evaluation.Results S-VEGF level of patients with esophageal squamous cell carcinoma was significantly higher than that of heahhy controls(475.93±44.76 pg/ml vs.294.20±23.40 pg/ml;P=0.020).S-VEGF levels in patients with StageⅢand StageⅣdisease were significantly higher than those in patients with Stage I and StageⅡdisease.The 1-year progress-free survival rate d high S-VEGF group(≥475 pg/ml)was significantly lower than that of the low S-VEGF group(＜475 pg/ml)(24% vs.66%;P=0.0004).The 1-year progress-free survival rate of the patients with StageⅠand StageⅡdisease was significantly higher than that of patients with StageⅢand StageⅣdisease(71% vs.29%;P=0.0015).The variables were assessed by multivariate analysis using the Cox proportional hazards model,and the results revealed that the clinical stage and the S-VEGF were first and second independent prognosis factor,respectively.Conclusions In the current study,a high S-VEGF was found to be associated with tumor progression,poor treatment response,and poor survival in patients with squamous cell carcinoma of the esophagus.

The determination of p53 protein and VEGF and MVD in esophageal squamous cell carcinoma and adjacent noncancerrous tissue and their relations

Expression of Human Vascular Endothelial Growth Factor in Ampullary Carcinoma and Its Significance

Expression of MDR1mRNA detected and its correlation with p53 in esophageal carcinoma by in situ hybridization

Expression of p53 and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinical significance]

P53 and Vascular Endothelial Growth Factor Expression in Esophageal Carcinoma and Their Relation to Angiogenesis in Carcinoma

Expression of P53, P16 and Cyclooxygenase-2 in Esophageal Cancer with Tissue Microarray

[Relationship Between Clinicopathologic Characteristics and Expression of VEGF-C and VEGF-D in Esophageal Squamous Cancer].

Prognostic Significance of Vascular Endothelial Growth Factor Expression and Microvessel Density in Carcinoma of Ampulla of Vater.

Clinical Significance of VEGF and MVD Expression in Esophageal Carcinomas

The clinical significance of p53 and pRb signal pathway in esophageal cancer patients

VEGF-C Expression and Clinical Significance in Esophageal Squamous Cell Carcinoma

The Expression and Clinical Significance of Vascular Endothelial Growth Factor-C in Gastric Cancer Tissues

Clinicopathological Significance of the Relationship Between Cell Proliferation and the Growth Characteristics of Vessel in Esophageal Squamous Carcinoma

The Expression and Correlation of HIF-1α,VEGF And EGFR Protein in Tissues Esophageal Squamous Cell Carcinoma

Expression of vascular endothelial growth factor and its correlation with clinicopathologi-cal characteristics in esophageal squamous cell cancer

Clinical Significance of S-VEGF in Patients with Esophageal Cancer

Correlation of P53 and Vascular Endothelial Growth Factor Expression to Angiogen Esis in Gastric Carcinoma and Its Clinical Significance

Expression of vascular endothelial growth factor and Survivin in esophageal cancer and their relations with pathological manifestation

Expression and Significance of NDRG1, P53 and VEGF in Esophageal Squamous Cell Carcinoma

Effects of lymphatic growth factor on angiogenesis,tumor metastasis and prognosis in esophageal squamous cell carcinoma

Expression of PC Cell-Derived Growth Factor and Vascular Endothelial Growth Factor in Esophageal Squamous Cell Carcinoma and Their Clinicopathologic Significance.